Business ❯ Pharmaceutical Industry ❯ Drug Development

Market Impact

Investor Relations Stock Performance Revenue Projections Consumer Health Zantac Sales Regulatory Challenges Investment Concerns Healthcare Innovations Eli Lilly Novo Nordisk

Pfizer Lung Cancer Drug Fails to Improve Survival in Late‑Stage Trial

The setback reduces near‑term prospects for the targeted antibody‑drug conjugate and shifts the program toward combination and earlier‑line studies.

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer